Menu

Recent Interviews

Ryan Jackson, CEO, Newlox Gold Ventures Corp.

Ryan Jackson
CEO | Newlox Gold Ventures Corp.
60 Laurie Crescent, V7S 1B7 West Vancouver (CAN)

info@newloxgold.com

+1 778 738 0546

Newlox CEO Ryan Jackson on building a green gold producer with a rapid growth trajectory


Nick Mather, CEO, SolGold PLC

Nick Mather
CEO | SolGold PLC
1 King Street, EC2V 8AU London (GB)

emichael@solgold.com.au

+44 20 3823 2125

SolGold CEO Nick Mather on building a major gold and copper mining company


Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca

Desert Gold Ventures CEO Jared Scharf on West Africa and its potential


05. November 2020 | 11:17 CET

NanoRepro, Osino Resources, Alibaba - Rich with special situations!

  • Investments
Photo credits: pixabay.com

The election outcome for the old or new President of the United States of America is taking longer than anticipated. The back and forth caused the first dip in the world stock markets yesterday until they hiked back into the green zone. The overall situation, whether Trump or Biden, hadn't changed. You can currently see a similar trend for individual stocks. After shifts or delays, stocks fall like stones, offering investors the chance of disproportionate price gains.

time to read: 2 minutes by Stefan Feulner


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


Better late than never!

For years, the shares of the rapid diagnostics manufacturer NanoRepro, based in Marburg an der Lahn, were bobbing along. The Company is one of the innovation leaders in the field of self-diagnostics and currently has 25 rapid tests in its portfolio - including an HIV test, two pregnancy tests and five more, purely for medical use. Then came Corona!

Size is an advantage

Thanks to its lean corporate structure, NanoRepro was able to react quickly and launched its first Corona antigen test at the end of September, which contributed a small six-figure sum to sales. However, the Company gave the go-ahead just under four weeks later. The test was approved by the Federal Institute for Drugs and Medical Devices (BfArM) as an antigen test for the direct detection of the coronavirus SARS-CoV-2.

Sales explosion leads to a re-evaluation

In 2019, the Marburg Company achieved an annual turnover of EUR 1,218,300. In comparison, the antigen test in the last two weeks of October brought in a volume of EUR 6 million. To satisfy the demand, NanoRepro offers three antigen tests from different suppliers, two of which are recognized by the Federal Institute for Drugs and Medical Devices (BfArM) and approved according to §1 Section 1 Clause 1 of the Coronavirus Test Regulation. The recognition of the third is to follow soon. We assume that the pandemic will not disappear overnight, and the strong demand for corona tests is likely to last even longer. A coup for NanoRepro!

Outstanding projects

The Namibian gold explorer Osino Resources has already scored a coup with its flagship project, Twin Hills Central. The area, which lies southwest of Otjikoto, has been defined so far with a length of 1.3 km. A first resource estimate is to be made here in early 2021.

Discovery well above expectations

The discovery drilling at Twin Hills at a depth of 65 metres and a gold grade of 1.37 grams per tonne, was so promising that the strip length has increased ten times. Several new targets have been defined along with the now 11-kilometre long gold system.

Analysts go on purchase

The analysts of the asset manager Echelon Capital Markets are bullish about the Company. For the Canadians, the Osino Resources share is a "top pick" for the fourth quarter of 2020 and thus a speculative buy. According to financial experts, the fair value of the Company is between CAD 2.30 and CAD 2.45. With a current share price of CAD 1.23, there is a chance that the share price will double.

Postponed is not cancelled

It was to be the largest IPO ever. Fintech heavyweight Ant Group wanted to raise USD 35 billion with the planned listing at a valuation of USD 200 billion, but the Shanghai Stock Exchange said "no". The group, which originated from the payment service Alipay, in which Alibaba still has a stake of about one third, would fail to meet the disclosure requirements due to changes in regulations, according to the stock exchange supervisory authority.

Delay triggers share price collapse
On Tuesday, Jack Ma, CEO of the parent Company Alibaba, was summoned to inform him about the temporary shutdown. After this announcement, Alibaba's shares fell by over 15% to 240 EUR from a high of 270 EUR. Of course, this decision is not final, and it would not be Jack Ma if there weren't a solution to every problem. The goal is undoubtedly to get rid of the 30% share package in the Ant Group.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

25. November 2020 | 11:44 CET | by Nico Popp

Sartorius, Drägerwerk, Desert Gold: Vaccines for the portfolio

  • Investments

The crisis is on the home stretch. Several vaccines have been found and are about to be approved. But it will still take a while before the pandemic is defeated: millions of people need to be vaccinated. Usually, two doses of vaccine are required for this purpose, which must be administered at specific intervals. This Herculean logistical task must succeed in many countries if normality is to be restored. This much seems inevitable: 2021 will still be under the influence of the virus. Corona also leaves its mark on the capital market, whether directly or indirectly.

Read

25. November 2020 | 11:15 CET | by Stefan Feulner

Moderna, Triumph Gold, BioNTech - bet on winners!

  • Investments

Gold has not made it out - for the time being. Due to the decision of the Americans pro Joe Biden and the very successful developments regarding a vaccine against the coronavirus, the precious yellow metal went downhill for the time being. The correction may well continue a little further. However, in the past, these setbacks were lucrative with anti-cyclical entry opportunities. Therefore, one should use the time now to take a closer look at promising gold mines.

Read

24. November 2020 | 10:38 CET | by Stefan Feulner

BYD, BIGG Digital Assets, NEL ASA - Get rich with these trends!

  • Investments

Hydrogen, blockchain or e-mobility, these new technologies are currently keeping investors busy. Leading stocks from the respective industries have gained several hundred percent in the past months. But these trends are only at the beginning of their development. In addition to the top performers, second and third-tier companies with novel business models are gradually moving forward. Further outperformers seem preprogrammed.

Read